Evidence map›Paper›PMID 36059818›Full record

ArticleFrontiers in medicine2022

Deep learning framework for prediction of infection severity of COVID-19.

Mehdi Yousefzadeh, Masoud Hasanpour, Mozhdeh Zolghadri, Fatemeh Salimi, Ava Yektaeian Vaziri, Abolfazl Mahmoudi Aqeel Abadi, Ramezan Jafari, Parsa Esfahanian, Mohammad-Reza Nazem-Zadeh

Abstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mehdi YousefzadehDepartment of Physics, Shahid Beheshti University, Tehran, Iran.
Masoud HasanpourResearch Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran.
Mozhdeh ZolghadriDepartment of Medical Physics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Fatemeh SalimiResearch Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran.
Ava Yektaeian VaziriDepartment of Medical Physics and Biomedical Engineering, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Abolfazl Mahmoudi Aqeel AbadiDepartment of Medical Physics and Biomedical Engineering, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Ramezan JafariDepartment of Radiology, Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Parsa EsfahanianSchool of Computer Science, Institute for Research in Fundamental Sciences (IPM), Tehran, Iran.
Mohammad-Reza Nazem-ZadehResearch Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the onset of the COVID-19 pandemic, quantifying the condition of positively diagnosed patients is of paramount importance. Chest CT scans can be used to measure the severity of a lung infection and the isolate involvement sites in order to increase awareness of a patient's disease progression. In this work, we developed a deep learning framework for lung infection severity prediction. To this end, we collected a dataset of 232 chest CT scans and involved two public datasets with an additional 59 scans for our model's training and used two external test sets with 21 scans for evaluation. On an input chest Computer Tomography (CT) scan, our framework, in parallel, performs a lung lobe segmentation utilizing a pre-trained model and infection segmentation using three distinct trained

Indexed as

COVID-19CT scandeep learninginfection segmentationlobe segmentationseverity score

Identifiers

PMID36059818
PMCPMC9428758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.